Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERIVERSION: Amiodarone Pre-ECV in Persistent AF
NCT06645249Phase 4Not yet recruiting
- Sponsor
- Institut d'Investigació Sanitària Pere Virgili
- Start
- Dec 2024
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amiodarone in Atrial fibrillation (AFib), sponsored by Institut d'Investigació Sanitària Pere Virgili. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT06645249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06645249.